BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4753432)

  • 1. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania.
    Vidor GI; Stewart JC; Wall JR; Wangel A; Hetzel BS
    J Clin Endocrinol Metab; 1973 Dec; 37(6):901-9. PubMed ID: 4753432
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and pathogenesis of iodine-induced thyrotoxicosis in Northern Tasmania.
    Stewart JC
    N Z Med J; 1975 Jan; 81(531):25-6. PubMed ID: 1055312
    [No Abstract]   [Full Text] [Related]  

  • 3. An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine.
    Connolly RJ
    Med J Aust; 1971 Jun; 1(24):1268-71. PubMed ID: 5565143
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to produce experimental autoimmune thyrotoxicosis in rabbits immunized with thyroidal microsomes.
    Wall JR; Good BF; Hetzel BS
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):703-6. PubMed ID: 4787506
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid antibodies and protein-binding of thyroxine in patients with and without thyrotoxicosis.
    Bános C; Takó J; Györgyi S; Juhász J; Sztraka I; Kapus I
    Endokrinologie; 1973 Jan; 61(1):32-6. PubMed ID: 4633897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Frequency of recurrence following treatment of hyperthyroidism with methimazole and suppressibility of the thyroid gland (author's transl)].
    Hackenberg K; Reinwein D; Schemmel K
    Munch Med Wochenschr; 1973 Dec; 115(49):2216-8. PubMed ID: 4205415
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
    Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
    J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 13. [New knowledge about the pathogenesis of hyperthyroidism].
    Küchel O; Horký K
    Cas Lek Cesk; 1969 Jul; 108(28):833-8. PubMed ID: 4978076
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting thyroid stimulator in thyrotoxic monozygous twins.
    Priest WM
    Br Med J; 1970 Jul; 3(5716):205. PubMed ID: 5311030
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
    Alford FP; Larkins RG; Martin FI
    Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
    [No Abstract]   [Full Text] [Related]  

  • 17. The long-acting thyroid stimulator.
    Munro DS
    Curr Top Exp Endocrinol; 1971; 1():175-98. PubMed ID: 4350824
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyrotoxicosis induced by iodine contamination of food--a common unrecognised condition?
    Stewart JC; Vidor GI
    Br Med J; 1976 Feb; 1(6006):372-5. PubMed ID: 946162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 20. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
    Letonturier P; Tourneur R; Sénécal P
    Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.